Reduce gap between doses of Covishield : Serum Institute urges Mansukh Mandaviya
The Serum Institute of India have urged the govt to reduce the gap between the second and third precautionary doses of COVID vaccine from 9 months to 3 months.
New Delhi: Serum Institute has urged Union Health Minister Mansukh Mandaviya to consider reducing the gap between the second and the precaution dose of Covishield from current nine months to three, in line with Centre's revised guidelines for officials on election duty, official sources said on Thursday.
The Pune-based firm also requested the minister to allow it to administer Covishield's precaution dose for all individuals aged above 18 years.
In a letter to Mandaviya, Prakash Kumar Singh, director, Government and Regulatory Affairs at SII, is learnt to stated that the third dose of COVID-19 vaccine is being administered within 6 months of the second dose in various countries and this schedule is giving very good results to control the infection, an official source said.
Singh also mentioned that private companies, educational institutions, social organizations, central government organizations as well as public undertaking companies etc. are continuously requesting the firm for the third dose of Covishield for their staff members and families.
He referred to Union Health Ministry's letter dated January 21 according to which the precaution dose can be administered 3 months after the second dose of the vaccine was given to officials and staff deployed on election duty in the poll-bound states of Goa, Manipur, Punjab, Uttarakhand and Uttar Pradesh.
For this, necessary changes have been made on the CoWIN portal to facilitate early administration of the precaution dose.
Till January 28, more than one crore people were administered the third dose of the COVID-19 vaccine out of which more than 90 lakh doses were of Covishield.
"In view of the above facts, we request for your kind intervention and consideration on our following submissions: The administration of third dose of our Covishield vaccine should be allowed for all individuals above the age of 18 years.
"The gap between second and third dose to be reduced and the administration of third dose of Covishield vaccine to be allowed after the completion of 3 months in line with revised guidelines of GoI for the officials and staff deployed on election duty," the official source quoted Singh as having said in the letter.
"Sir, it is need of the hour and in the interest of public at large... This will help to control unpredictable and fast spread of various strains of COVID-19 which is disrupting economy and social stability of our country," Singh said in the letter.
Our comments section is governed by our Comments Policy . By posting comments at Medical Dialogues you automatically agree with our Comments Policy , Terms And Conditions and Privacy Policy .
Disclaimer: This website is primarily for healthcare professionals. The content here does not replace medical advice and should not be used as medical, diagnostic, endorsement, treatment, or prescription advice. Medical science evolves rapidly, and we strive to keep our information current. If you find any discrepancies, please contact us at corrections@medicaldialogues.in. Read our Correction Policy here. Nothing here should be used as a substitute for medical advice, diagnosis, or treatment. We do not endorse any healthcare advice that contradicts a physician's guidance. Use of this site is subject to our Terms of Use, Privacy Policy, and Advertisement Policy. For more details, read our Full Disclaimer here.
NOTE: Join us in combating medical misinformation. If you encounter a questionable health, medical, or medical education claim, email us at factcheck@medicaldialogues.in for evaluation.